scispace - formally typeset
B

Bent Faber Vestergaard

Researcher at Statens Serum Institut

Publications -  28
Citations -  1056

Bent Faber Vestergaard is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 14, co-authored 28 publications receiving 1025 citations.

Papers
More filters
Journal ArticleDOI

Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

TL;DR: Both antigenaemia and the disappearance of antibodies to the core protein were associated with development of the acquired immune deficiency syndrome (AIDS) or AIDS related complex and depletion of CD4 cells.
Journal ArticleDOI

Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case–control study nested in a cohort of Norwegian blood donors

TL;DR: Cytokines and cytokine-related markers appear to be upregulated rather late in RA pathogenesis, and IgM rheumatoid factor and IgG anti-cyclic citrullinated peptide autoantibodies may precede the diagnosis of RA by up to two decades.
Journal ArticleDOI

Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study.

TL;DR: The finding of a higher HPV infection rate in Denmark than in Greenland, opposed to cervical cancer rates, does not support a role for these viruses as determinants of cervical cancer incidence.
Journal ArticleDOI

Risk factors for cervical human papillomavirus and herpes simplex virus infections in greenland and denmark: a population-based study

TL;DR: A surprising risk pattern for HPV types 6/11 and 16/18 is demonstrated, but a pattern for HSV-2 in line with that to be expected for a sexually transmitted virus is demonstrated.
Journal ArticleDOI

An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors

TL;DR: To estimate the incidence of human parvovirus B19 among pregnant women before and during an epidemic, to elucidate possible sociodemographic and medical risk factors during pregnancy and to estimate the association betweenParvov virus B19 infection and negative pregnancy outcome.